Inhibition of signal transducer and activator of transcription 3 and cyclooxygenase-2 is involved in radiosensitization of cepharanthine in HeLa cells

International Journal of Gynecological Cancer

Volumn 23, Issue 4, 2013, Pages 608-614

  Fang, Zhen Hao ^a   Li, Yan Jing ^a   Chen, Zan ^a   Wang, Jun Jie ^a   Zhu, Li Hong ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Cepharanthine; COX 2; HeLa; Radiosensitization; STAT3

Indexed keywords

CEPHARANTHINE; CYCLOOXYGENASE 2; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BCL2 GENE; CANCER INHIBITION; CERVICAL ADENOCARCINOMA; CYTOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIZATION; TUMOR XENOGRAFT; UTERINE CERVIX CARCINOMA; WESTERN BLOTTING;

APOPTOSIS; BENZYLISOQUINOLINES; CYCLOOXYGENASE 2 INHIBITORS; HELA CELLS; HUMANS; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 84879962650     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31828a05fd     Document Type: Article

References (18)

1. Barbera L, Thomas G. Management of early and locally advanced cervical cancer. Semin Oncol. 2009;36:155-169.
2. Shukla S, Shishodia G, Mahata S, et al. Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection. Mol Cancer. 2010;9:282.
3. Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;21:11-19.
4. Ishikawa H, Ohno T, Kato S, et al. Cyclooxygenase-2 impairs treatment effects of radiotherapy for cervical cancer by inhibition of radiation-induced apoptosis. Int J Radiat Oncol Biol Phys. 2006;66:1347-1355.
5. Xia S, Zhao Y, Yu S, et al. Activated PI3K/Akt/COX-2 pathway induces resistance to radiation in human cervical cancer HeLa cells. Cancer Biother Radiopharm. 2010;25:317-323.
6. Furusawa S, Wu J. The effects of biscoclaurine alkaloid cepharanthine on mammalian cells: implications for cancer, shock, and inflammatory diseases. Life Sci. 2007;80:1073-1079.
7. Zhou Y, Hopper-Borge E, Shen T, et al. Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance. Biochem Pharmacol. 2009;77:993-1001.
8. Chen Z, Huang C, Yang YL, et al. Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells. Acta Pharmacol Sin. 2012;33:101-108.
9. Seubwai W, Vaeteewoottacharn K, Hiyoshi M, et al. Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-kappaB. Cancer Sci. 2010;101:1590-1595.
10. Tamatani T, Azuma M, Motegi K, et al. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells. Int J Oncol. 2007;31:761-768.
11. Deorukhkar A, Krishnan S. Targeting inflammatory pathways for tumor radiosensitization. Biochem Pharmacol. 2010;80:1904-1914.
12. Chen CL, Hsieh FC, Lieblein JC, et al. Stat3 activation in human endometrial and cervical cancers. Br J Cancer. 2007;96:591-599.
13. Wu J, Suzuki H, Zhou YW, et al. Cepharanthine activates caspases and induces apoptosis in Jurkat and K562 human leukemia cell lines. J Cell Biochem. 2001;82:200-214.
14. Biswas KK, Tancharoen S, Sarker KP, et al. Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1/2 and the downregulation of Akt. FEBS Lett. 2006;580:703-710.
15. Bonner JA, Trummell HQ, Willey CD, et al. Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma. Radiother Oncol. 2009;92:339-344.
16. Lin S, Li S, Chen Z, et al. Formation, recognition and bioactivities of a novel G-quadruplex in the STAT3 gene. Bioorg Med Chem Lett. 2011;21:5987-5991.
17. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007;7:454-465.
18. Raju U, Nakata E, Yang P, et al. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations. Int J Radiat Oncol Biol Phys. 2002;54:886-894.